Pronađeno: 1-10 / 66 radova

Autori: Kandolf-Sekulovic Lidija O

>> Filter: Samo Article i Review

>> Sve godine

Vidi i: Kandolf Lidija O

Naslov European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023 (Article)
Autori Stratigos Alexander J ... Kandolf-Sekulovic Lidija O ... (broj koautora 35) 
Info EUROPEAN JOURNAL OF CANCER, (2023), vol. 193 br. , str. -
Projekat EADO
Ispravka Web of Science   Članak   Elečas   Rang časopisa  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023 (Article)
Autori Stratigos Alexander J ...  Hauschild Axel ... Kandolf-Sekulovic Lidija O ... (broj koautora 40) 
Info EUROPEAN JOURNAL OF CANCER, (2023), vol. 193 br. , str. -
Projekat funds of the EADO
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Prediction of Additional Regional Lymph Node Metastases in Cutaneous Melanoma Patients With Positive Sentinel Lymph Node Biopsy (Meeting Abstract)
Autori Radosavcev L Rajovic Milica I Radulovic Marija Petrov Nenad Kandolf-Sekulovic Lidija O 
Info EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, (2023), vol. 50 br. SUPPL 1, Suppl. 1, str. S196-S196
Ispravka Web of Science   Elečas   Rang časopisa  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial (Article)
Autori Livingstone E ... Kandolf-Sekulovic Lidija O ... Mijuskovic Zeljko P  ... (broj koautora 24) 
Info EUROPEAN JOURNAL OF CANCER, (2023), vol. 190 br. , str. -
Projekat F. Hoffmann-La Roche Ltd
Ispravka Web of Science   Članak   Elečas   Rang časopisa  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov The Prognostic and Predictive Value of Human Gastrointestinal Microbiome and Exosomal mRNA Expression of PD-L1 and IFN & gamma; for Immune Checkpoint Inhibitors Response in Metastatic Melanoma Patients: PROTOCOL TRIAL (Article)
Autori Erman Ana Ignjatovic Marija Leskovsek Katja Miceska Simona Tratar Ursa Lampreht Bosnjak Masa Kloboves-Prevodnik Veronika Cemazar Maja Kandolf-Sekulovic Lidija O Avgustin Gorazd Ocvirk Janja Mesti Tanja 
Info BIOMEDICINES, (2023), vol. 11 br. 7, str. -
Projekat Slovenian Research Agency (ARRS) [P3-0321]
Ispravka Web of Science   Članak   Elečas   Rang časopisa  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Mucous membrane pemphigoid-a report of four cases (Article)
Autori Jocic Ivana Dakovic Dragana R Kandolf-Sekulovic Lidija O Novakovic Ljubomir Mijuskovic Zeljko P  
Info VOJNOSANITETSKI PREGLED, (2023), vol. 80 br. 1, str. 90-94
Ispravka Web of Science   Članak   Elečas   Rang časopisa  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox study (Article)
Autori L'Orphelin J-M ... Kandolf-Sekulovic Lidija O ... Dujovic B ... (broj koautora 22) 
Info JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, (2023), vol. 37 br. 8, str. 1606-1615
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati:
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment (Article)
Autori Garbe Claus ... Kandolf-Sekulovic Lidija O ... (broj koautora 27) 
Info JOURNAL OF CLINICAL ONCOLOGY, (2022), vol. 40 br. 32, str. 3741-+
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Outcome of PD-1 inhibitor therapy of advanced melanoma patients according to demographic factors in a real-world setting across Europe (Meeting Abstract)
Autori Weichenthal Michael ... Kandolf-Sekulovic Lidija O ... (broj koautora 20) 
Info ANNALS OF ONCOLOGY, (2022), vol. 33 br. 7, Suppl. 7, str. S931-S931
Projekat Novartis AG; Merck Co., Inc.; Bristol Myers Squibb
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAF(V600)-positive melanoma: Interim analysis of the ImmunoCobiVem study. (Meeting Abstract)
Autori Schadendorf Dirk ... Kandolf-Sekulovic Lidija O ... Mijuskovic Zeljko P  ... (broj koautora 20) 
Info JOURNAL OF CLINICAL ONCOLOGY, (2022), vol. 40 br. 16, Suppl. S, str. -
Projekat F. Hoffmann-La Roche Ltd.
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Vidi i: Kandolf Lidija O

Ispis zapisa u formatu:TXT | BibTeX